Here, we investigated expression of 5-Lox, the rate limiting enzyme in LT production, and of FLAP, the 5-Lox activating protein, in the brain of wild-type (WT) and of transgenic AD mice (APP-PS1 mice) as well as in human post-mortem brain specimen of AD patients. This evidence concerns the gene APP and Alzheimer disease.